Medpace Holdings, Inc.·4

Mar 8, 5:02 PM ET

Medpace Investors, LLC 4

4 · Medpace Holdings, Inc. · Filed Mar 8, 2024

Insider Transaction Report

Form 4
Period: 2024-03-06
Transactions
  • Sale

    Common Stock

    2024-03-06$412.98/sh100,000$41,298,0004,833,019 total
  • Sale

    Common Stock

    2024-03-07$410.74/sh75,000$30,805,5004,758,019 total
  • Sale

    Common Stock

    2024-03-08$408.71/sh25,000$10,217,7504,733,019 total
Footnotes (4)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
  • [F2]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
  • [F3]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
  • [F4]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

Documents

1 file
  • 4
    wk-form4_1709935342.xmlPrimary

    FORM 4